RxDoctor Payments Data

Deborah Christiansen

Developmental - Behavioral Pediatrics · Knoxville, TNNPI 1689764656

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $91,175 of the $108,087 with a category attached, or 84.4%. Supernus Pharmaceuticals, Inc. accounts for 98.6% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $25,292, more than ten times the $288 reported in 2019.

$108,087in general payments, 2019–2025

Across 293 payments — averaging $368.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$107K
  • Tris Pharma Inc$494
  • Ironshore Pharmaceuticals Inc.$454
  • Corium, LLC$280
  • Neos Therapeutics, LP$124
  • GSK$44
  • plus $139 from 5 others

What the payments were for

  • Speaking & faculty fees$91,17584%
  • Travel & lodging$11,97611%
  • Food & beverage$4,9365%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few developmental - behavioral pediatrics providers in Tennesseeto place this figure against a meaningful peer group, so we don't.

Other developmental - behavioral pediatrics in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →